Pepro Tech

This Article
Right arrow Correction (v83,p797)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodie, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodie, S. J.
(Journal of Leukocyte Biology. 2000;68:351-359.)
© 2000 by Society for Leukocyte Biology

Nonlymphoid reservoirs of HIV replication in children with chronic-progressive disease

Scott J. Brodie

University of Washington School of Medicine, Virology Division, Retrovirology Laboratory, Seattle, Washington

Correspondence: Dr. Scott J. Brodie, University of Washington School of Medicine, Department of Laboratory Medicine, Vaccine/Virology Division, Room T293X, Seattle, WA 98195.


arrow
ABSTRACT
 
Autopsy tissues from 2 cohorts of age-matched HIV-infected children with similar plasma viral load (>105 HIV RNA copies/ml), but with distinct AIDS-associated disease manifestations, were examined for sites of persistent HIV replication. One group consisted of 3 children with severe lymphoid atrophy and peripheral blood CD4+ T cell counts of <10/mm3. Another group was composed of 6 children with extensive hyperplasia of mucosal-associated lymphoid tissues and blood CD4+ T cell counts >500/mm3. Hyperplastic bronchiole- and gut-associated lymphoid tissues were characterized by extensive networks of germinal center follicular dendritic cells (FDC) containing large amounts of immune-complexed virion RNA. Conversely, pulmonary and gastrointestinal tissues from children with severe CD4+ T cell depletion were devoid of any secondary lymphoid structures, yet these tissues also harbored high concentrations of HIV RNA. Dual in situ procedures showed that only macrophage (M{phi}) within these sites contained tat fusion transcripts, a product of post-transcriptional splicing and a correlate of productive infection. When examining explant cultures of M{phi} and FDC, only M{phi} harbored HIV tat mRNA and only M{phi} demonstrated budding retroviral particles. Hence, germinal center FDC in secondary lymphoid tissues are key reservoirs of immune-complexed HIV RNA and are likely to contribute to AIDS-associated lymphoproliferations; however, these cells do not support HIV replication, and failure to do so results from a post-transcriptional block in the virus life cycle. Moreover, gut and pulmonary M{phi} represent a lineage of cells that are permissive to HIV replication and contribute significantly to the high viral load in children with severe CD4+ T cell depletion. It will be important to identify the molecular mechanisms that allow for these highly productive infections of M{phi}.

Key Words: BALT • GALT • macrophages • follicular dendritic cells • peripheral blood lymphocytes


arrow
INTRODUCTION
 
Conceptually, there are two types of reservoirs of human immunodeficiency virus type-1 (HIV): anatomical and cellular. Anatomical reservoirs include structures that are immunologically sheltered or separated by barrier from the peripheral blood and lymphoid systems and include the central nervous system (CNS) [1 , 2 ], male genital tract [3 , 4 ], and perhaps the developing fetus [5 , 6 ]. Still, other sites of virus replication likely exist that are not fully amenable to immune surveillance and/or effective antiretroviral drug penetration. The respiratory [7 8 9 10 ], gastrointestinal [11 12 13 ], and female reproductive [6 , 14 ] tracts have recently received attention as sites of both early and late HIV replication, and as potential sanctuaries of persistent HIV replication.

Four potential cellular reservoirs of HIV replication thus far have been identified: activated CD4+ T lymphocytes [11 , 14 , 15 ]; blood monocytes [16 , 17 ]; macrophages (M{phi}) of various lineage [8 , 18 19 ], characterized by their long life-span [20 ] and ability to express HIV for prolonged periods [21 ]; and follicular dendritic cells (FDC), which can store large quantities of virus [22 23 24 25 26 ]. It is clear that FDC are important in maintaining HIV infection of lymph node germinal centers and can transmit virus to activated CD4+ T cells [27 28 29 30 31 ]. It is not clear whether FDC support HIV replication in vivo [32 33 34 35 36 ], because it is difficult to demonstrate by in situ hybridization and by transmission electron microscopy the exact location of virus within these cells. Few studies have examined virus replication in mature explant-derived FDC and none in the context of alternatively spliced viral transcripts as correlates of productive infection. Here, we present a possible explanation of the pathobiology of persistent HIV replication, based on observations that some children with severe depletion of CD4+ T cells maintain high plasma viral load and recent demonstrations that combination antiretroviral therapy effectively extinguishes FDC reservoirs of virus [37 38 39 ] yet virus replication persists in most individuals [40 41 42 43 ].


arrow
MATERIALS AND METHODS
 
Experimental design
A total of 9 children (mean age 5.6 ± 1.5 years) with perinatal-acquired HIV infection were studied for sites of persistent virus replication (Table 1) . All died from AIDS-associated complications and all were classified as P2-C (symptomatic) according to the CDC control and prevention classification system [44 ]. One group was composed of 6 children (Child 1–6) with extensive hyperplasia of mucosal-associated lymphoid tissues and blood CD4+ T cell counts >500/mm3. Another group consisted of 3 children (Child 7–9) with severe lymphoid atrophy and peripheral blood CD4+ T cell counts of <10/mm3. Two children (Child 6 and 9) had received ineffective therapy (AZT) based on the observation that their plasma HIV RNA set-point was not altered by therapy.


View this table:
[in this window]
[in a new window]
 
Table 1. Persistent reservoirs of HIV replication

Clinical samples
Peripheral blood mononuclear cells (PBMC) were separated into CD4+ T lymphocytes (PBL) by adherence and magnetic bead elutriation techniques [15 , 45 , 46 ]. Postmortem tissues included cerebral cortex, periventricular white matter, right caudal lung lobe, spleen, lymph nodes (submandibular, caudal mediastinal, axillary, inguinal, and/or mesenteric), and distal colon. Tissues were fixed in 4% deionized paraformaldehyde, embedded in paraffin wax, and sectioned to a thickness of 5 µ after standard procedure [10 , 47 ]. Tissues were also snap-frozen in OCT compound (Miles, Elkhart, IN) for detection of cellular antigens by immunohistochemistry and immunofluorescence [48 ].

Plasma antigen and virus isolation
Plasma was assessed for HIV RNA using the bDNA assay (Chiron, Norwood, MA), which has a lower limit of detection of 500 HIV RNA copies/ml [49 ]. Isolation of infectious HIV and quantitative microculture was performed as described previously [50 ]. A minimum of 107 cells were applied to phytohemagglutinin-stimulated and interleukin-2 (IL-2)-treated HIV-negative donor PBMC (Table 1) . Serological tests to detect antibodies to human herpesvirus 8 (HHV-8) used an immunofluorescence assay for lytic cycle cytoplasmic antigen and were performed as described previously [10 , 51 , 52 ].

Cell purification
Peripheral blood and tissue lysates were applied to discontinuous density gradients, washed, and resuspended in RPMI 1640, followed by a 1-h incubation (37°C and 5% CO2) in fibronectin-coated flasks (20 µg/ml), whereby adherent cells were removed. The nonadherent lymphocyte-enriched population was labeled with magnetic bead-conjugated monoclonal antibodies (mAbs) (4:1 bead:cell ratio; Dynal, Great Neck, NY) to CD8, CD14, CD16, CD19, CD20, and CD21 to enrich for CD4+ T cells. The CD4+ cells were then sorted (FACS, fluorescence activated cell sorting) for CD45RO+ memory T cells. Tissue FDC were isolated from lung explants in the presence of GM-CSF, TNF-{alpha}, and IL-4 [53 , 54 ]. FDC were further purified using negative selection and magnetic bead elutriation [33 ] until an immunomorphologically pure CD1a+, B7/BB1+, HLA-2+, and CD4+ (low) population was obtained. FDC were nonadherent, nonphagocytic, and had a veiled surface appearance. Tissue M{phi} were initially isolated by adherence, enriched using magnetic bead elutriation (anti-CD68, clone EBM11, DAKO), and then sorted to high-purity. By combining magnetic bead elutriation and FACS, >99% of isolated cells were immunophenotypically compatible with memory (CD45RO+) PBL, CD68+ (esterase+) M{phi}, and CD1a+ FDC, respectively. Unless otherwise indicated, all mAbs were products of PharMingen (San Diego, CA).

Quantitative fluorescent probe polymerase chain reaction (TaqMan)
DNA and RNA were extracted (QIAmp DNA and RNA kits; Qiagen, Santa Clarita, CA) from cultured cells as described previously [55 ]. HIV tat RNA and tat fusion mRNA were reverse-transcribed in a solution containing 1.25 mM MgCl2, 10 mM dithiothreitol, 10 mM Tris-HCl pH 8.3), 50 mM KCl, 2.0 mM of each dNTP, 10 pM of specific antisense primer (below), 200 U Superscript II reverse transcriptase (RT) (Gibco BRL, Grand Island, NY), and 4 µl (2 µg) of RNA in a 20-µl reaction. High-purity DNA and cDNA were then applied at a final concentration of 0.5 µg per well and TaqMan performed on samples in quadruplicate. The amplification mix and polymerase chain reaction (PCR) conditions for a 50-µl reaction consisted of 1X PCR buffer II, 8% glycerol, 1.0 U AmpErase (uracil glycoslase; Epicenter, Madison, WI), 2.5 U AmpliTaq DNA polymerase (Perkin-Elmer), 4 mM MgCl2, 200 µM dATP, dGTP, dCTP, and 400 µM dUTP, 30 µmol of forward MF5869 (5'-GCGAATTCATGGAKCCAGTAGATCCTAGACTA-3' [nt 5869–5886]) and reverse MF8760 (GCTCTAGACTACTGTCCCCTCAGCTACTGCTATGG-3' [nt 8760–8733]) of HIV strain HXB2, respectively, and 20 µmol TaqMan probe (MF5945, 5'-ATTGTAAAAAGTGTT-splice-GCTWTCATTGC-3'). The designation K refers to the single-code letter for G or C, and W refers to A or T for degenerative bases. Tat plasmids were provided by Dr. Manohar Furtado and have been described previously [56 ]. TaqMan primers and probes for HIV gag have been described [48 ]. HIV DNA and RNA concentrations in test samples were determined by coamplification of ß-actin and GADPH (Perkin-Elmer), respectively. Target and control DNA/cDNA were subjected to 50°C for 2 min and 95°C for 10 min, followed by 42 cycles of amplification at 95°C for 20 s and 60°C for 1 min, using ABI PRISM 7700 sequence detector (Perkin-Elmer). Assay controls consisted of ACH-2 cell DNA and armored RNA (Ambion, Austin, TX) as standards [48 ], as well as nucleic acid derived from PBL, M{phi}, and FDC of HIV-seronegative children [10 ].

PCR in situ hybridization
PCR in situ hybridization (PCR-ISH) was used to localize HIV DNA to cultured cells and to cells within tissues. Tissue sections were deparaffinized, rehydrated in Tris-buffered saline (TBS; 0.1 M Tris [pH 7.5], 0.1 M NaCl), digested with proteinase K (20 (g/ml, 37°C, 30 min; Sigma, St. Louis, MO), and washed in DEPC water. Fifty µl of a solution containing 1X PCR buffer, 4 mM MgCl2, 0.01% gelatin, 200 µM dNTPs, 50 pM of HIV gag-specific primers [55 ] and Taq polymerase (0.15 U/µl) was applied to tissues. Thermocycling conditions were the same as described previously [47 , 55 ]. The PCR product was detected by ISH using a cocktail of 3 HIV gag-specific oligonucleotides labeled with digoxigenin-11-dUTP (DIG, Boehringer Mannheim, Indianapolis, IN), and all were in sense orientation and internal to the PCR primer-binding sequences (SK102, 5'-GAGACCATCAATGAGGAAGCTGCAGAATGGGAT; SK19, 5'-ATCCTGGGATTAAATAAAATAGTAAGAATGTATAGCCCTAC; and SJB9I, 5'-CTGTTCCTGGTTTCCTTGGGAAATCTCTGA). Hybridization conditions and controls were as described previously [47 , 55 ]. The presence of HIV DNA was indicated by a purple cell-associated precipitate and visualized by incident light microscopy. Images from 10 representative regions of the tissue were transmitted to a computer equipped with a digital imaging board and an average viral load was determined [48 ].

Combined immunohistochemistry and in situ hybridization
Immunohistochemistry was used in combination with ISH to identify cells expressing viral RNA (Fig. 2), as described previously [10 ]. For fresh cells and frozen tissues, CD45RO+ PBL, CD19+ B cells, CD68+ M{phi}, and CD1a+ FDC were localized in the context of HIV gag-pol, EBV EBER1, and HHV-8 orf 26 RNA expression. RNA encoding HIV gag p24 (0.8 kb) and pol (0.7 kb) was cloned into transcription vectors under the control of T7 and SP6 RNA polymerase promoters (pGEM; Promega, Madison, WI), using methods described previously [47 , 55 ]. RNA-encoding EBER1 and orf 26 were as described previously [10 , 51 , 52 ]. The constructs were linearized and used as templates for in vitro transcription to which DIG-11-UTP (Boehringer Mannheim) was incorporated. Tissue preparation and hybridization procedures were as described previously [10 , 51 , 52 ]. The presence of viral nucleic acid was indicated by a purple/brown cell-associated precipitate and visualized by incident light microscopy. Tissues labeled with fluorescent probes were visualized directly with an ACAS 570 laser confocal microscope [48 ]. The lower limit of detection was <=20 RNA copies per cell [51 , 52 ].

A separate in situ hybridization method was used to detect immune-complexed HIV RNA associated with germinal center FDC. 35S-labeled CTP (Amersham, Arlington Heights, IL) was incorporated into gag and pol riboprobes (described above), which were then applied to protease K-treated tissues (5 µg/ml, 37°C, 30 min; Sigma), as described [10 ]. This technique can identify cells with as few as 5 gag-pol RNA copies and can also be used as means to gauge the amount of germinal center HIV RNA when examined using low-power dark-field microscopy.

Transmission electron microscopy
FDC and M{phi} derived from tissue explants were fixed in half-strength Karnovsky’s fixative, washed in 0.1 M cacodylate buffer, postfixed in 1% osmium tetroxide, dehydrated, treated with propylene oxide, and embedded in Epon. Embedded cells were cut in ultrathin sections, stained with uranyl acetate and lead citrate, and analyzed with a JOEL 100S transmission electron microscope.


arrow
RESULTS
 
Anatomic reservoirs
The amount of HIV RNA in samples of brain, colon, lung, spleen, and lymph node was determined by fluorescent probe PCR (Fig. 1) . Viral RNA was detected in periventricular white matter from 1 child with lymphoid atrophy (Child 8) and 2 children with opportunistic lymphoproliferations (Child 1 and 4), but was at much lower titer when compared with equivalent amounts of tissue (cellular DNA equivalent) derived from the other sites. In general, tissues with lymphoproliferation contained higher concentrations of gag RNA (P = 0.05, one-way ANOVA). The exception was lung from children with severe lymphoid atrophy, which, of all tissues evaluated, contained the highest amount of gag RNA. These levels were significantly higher than gag RNA levels from lung of children with opportunistic lymphoproliferations (P = 0.02, Mann-Whitney U test) (Fig. 1) .



View larger version (27K):
[in this window]
[in a new window]
 
Figure 1. Quantification of HIV RNA in postmortem tissues using fluorescent probe PCR. Results represent the mean and SEM of 4 replicate samples and are expressed as HIV gag RNA copies per ng of total cellular DNA (1 ng cellular DNA (150 cells). Tissues include periventricular white matter, caudal lung lobe, spleen, caudal mediastinal lymph node, and distal colon. Open characters identify subjects with AIDS-associated opportunistic lymphoproliferations. Closed characters identify children with severe late-stage lymphoid. Bars indicate the median gag RNA copy number where statistically relevant.

Cellular reservoirs of HIV replication
Pulmonary- (Fig. 2AI ) and gut-associated (Fig. 2BI ) lymphoid tissues from children with opportunistic lymphoproliferations showed expansive networks of germinal center FDC (Fig. 2AIV ). Within lung, these FDC were heavily integrated with immature B cells. M{phi} expressing HIV RNA (Fig. 2AII and BII ) and viral core proteins (Fig. 2AIII ) localized peripheral to hyperplastic BALT and GALT. Large accumulations of germinal center HIV RNA were detected in conjunction with proteolytic digestion (Fig. 2AV and BIII ), indicating that virus bound to FDC was protein-coated (immune-complexed). A high proportion (5–20%) of germinal center B cells expressed EBV EBER1 RNA (Fig. 2E ). However, there was no evidence of opportunistic herpesvirus infections of GALT or in any of the other tissues examined. Only 1 child (Child 8) demonstrated CNS disease. A thorough histolopathological evaluation revealed multifocal granulomatous lesions (Fig. 2CI ) containing gag p24 immunoreactive multinucleated giant cells (Fig. 2CII ) within periventricular white matter.



View larger version (99K):
[in this window]
[in a new window]
 
Figure 2. Representative histomorphology (AI, BI, CI) and sites HIV (AII, BII, BIII) and EBV (E) RNA localization in sections of caudal right lung (AI–V, E) and distal colon (BI–III) from a child (Child 2) with severe multicentric lymphoid hyperplasia, and periventricular white matter (CI, II) from a child (Child 8) with severe lymphoid atrophy. Note that there is marked expansion of bronchiole-associated lymphoid tissue and ;250q;;25>diffuse thickening of the pulmonary interstitium (AI, H, E). Cells harboring gag RNA (panel AII, 35S-riboprobes) and gag proteins (panel AIII, anti-p24 HPO) were morphologically compatible with interstitial lymphocytes and M{phi} (arrows). Large amounts of HIV RNA aggregated within lymphoid germinal centers (panel AIV, anti-CD21 HPO) and localized to FDC (panel AV, 35S-riboprobes, dark-field). Gut-associated lymphoid tissue (BI, H, E) contained high numbers of mononuclear cells harboring HIV RNA (BII) within perifollicular and intervillous spaces (DIG-riboprobes, anti-DIG-AP). Large aggregates of HIV RNA were present within lymphoid germinal centers (panel BIII, 35S-riboprobes, dark-field). Only 1 child (Child 8) demonstrated lesions within the periventricular white matter characteristic of AIDS-associated granulomatous encephalitis (CI, H, E). Note the high number of gag p24 immunoreactive multinucleated giant cells (panel CII, anti-p24 HPO). A detailed ultrastructural study of pulmonary FDC revealed HIV particles to be adherent to the cell body and dendritic processes (DI), whereas pulmonary M{phi} demonstrated both intracytoplasmic and budding retroviral particles (DII) (-50,000). Pulmonary lymphoid hyperplasia was invariably associated with a high proportion of germinal center B cells expressing EBV EBER1 RNA (panel E, DIG-riboprobes, anti-DIG-AP). (Bars = 100 µm).

Children with severe lymphoid atrophy had remarkably high HIV RNA concentrations in lung tissues (Fig. 1) . One of these children (Child 8) also demonstrated comparatively high concentrations of HIV RNA within extracts from gastrointestinal tissues (Fig. 1) , as showed relatively high numbers of M{phi}-expressing gag-pol RNA in histologic sections of distal colon (Table 1) . Tissues that would normally be lymphocyte-rich, such as the pulmonary interstitium (Fig. 3A ) and mediastinal lymph node (Fig. 3D ) were severely hypocellular. A thorough evaluation of these tissues using a combination of immunohistochemical and in situ hybridization procedures showed that lung, and to a lesser extent gut, harbored high numbers of cells expressing gag-pol RNA (Fig. 3Ci ). Dual-staining techniques, when applied to histologic sections of lung, showed that these RNA-positive cells were unequivocally alveolar and interstitial macrophages (Fig. 3Cii ). Similar observations were made within sections of distal colon; only mucosal M{phi} harbored HIV RNA in tissues demonstrating severe lymphoid atrophy. FDC reservoirs of virus were not observed in children with lymphoid atrophy. Moreover, protease treatment neither increased the number of HIV RNA-positive cells nor did it reveal areas of residual FDC-associated HIV. Rather, viral expression localized exclusively to M{phi}.



View larger version (117K):
[in this window]
[in a new window]
 
Figure 3. Representative histomorphology (A, D) and sites of localization of HIV gag DNA (B, E) and gag-pol RNA (C, F) in sections of caudal right lung (A–C) and caudal mediastinal lymph node (D–F) from a child (Child 7) with severe lymphocyte depletion and AIDS. Note the hypocellularity of the pulmonary interstitium (A) and mediastinal lymph node (D, H, E). gag DNA localized to round cells with lymphocyte morphology (open arrows) and to stromal cells with M{phi}-like features (closed arrows) in both lung (B) and lymph node (E) (PCR-ISH, anti-DIG-AP). Cells expressing gag-pol RNA were only detected in the lung (panel Ci; ISH, anti-DIG-AP) and not in the accompanying mediastinal lymph node, and were shown by dual staining to be exclusively alveolar and interstitial macrophages (panel Cii; IHC and ISH, PE-anti-CD68 and FITC-anti-gag-pol). Controls consisted of plasma clot preparations of HIV-infected (G, arrows) and uninfected (H, arrows) MT2 cells, lung tissue from an HIV-seronegative child (I, J), and lung from a child with high titers of HIV RNA (K, L) [10 ]. Control tissues were hybridized with sense (I, K) and antisense (G, H, J) gag-pol riboprobes, and with nonsense bluetongue virus RNA probes [47 ] (L) (anti-DIG-AP). (Bars = 100 µm).

Children with lymphoid atrophy and blood CD4+ T cells <10/mm3 had remarkably similar levels of plasma HIV RNA (mean, 222,850 gag copies/ml) when compared with children with >500 CD4+ T cells/mm3 of blood (mean, 197,308 gag copies/ml) (P = 0.8, unpaired t-test) (Table 1) . Replication of HIV in M{phi} was the best predictor of plasma viremia in these severely lymphopenic children (Table 2) . M{phi} and FDC derived from explant cultures of secondary lymphoid tissues and PBL were assayed for spliced and unspliced HIV tat RNA. All cells harbored unspliced tat, but only PBL and M{phi} contained tat fusion transcripts, products of post-transcriptional splicing and a correlate of productive infection [15 , 41 ]. The ratio of spliced to unspliced tat varied per cell type and per disease state. FDC contained the highest proportion of unspliced tat RNA (Table 2) , levels that corresponded with concentrations found in germinal centers (Table 1) ; still, these FDC showed no evidence of fusion mRNA. These relatively high concentrations of unspliced HIV RNA were likely the result of virion RNA bound to the cell surface and/or harbored within intracytoplasmic vesicles that were not completely removed by protease treatment. Still, based on a variety of assays that detected only HIV DNA, including PCR in situ hybridization, virus was able to enter FDC and at least partially reverse transcribe. Moreover, after >3 weeks in culture and multiple treatments with trypsin, the cultivated FDC still harbored unspliced tat transcripts, but at a 10-fold reduction in concentration (not shown), indicating that these cells were permissive to infection and virus transcription. Because these cells showed no evidence of spliced tat mRNA and did not produce infectious virus (Table 2) , the defect in virus replication most likely occurred at the level of post-transcriptional ligation. In contrast, pulmonary M{phi} from lymphopenic children produced high titers of tat fusion mRNA, levels much higher than children with lymphoproliferative disease (P = 0.016, unpaired t-test) (Table 2) . When comparing viral titers in PBL and M{phi} from children with opportunistic lymphoproliferations, there was no difference in the amount of unspliced (P = 0.1, unpaired t-test) and spliced (P = 0.7, unpaired t-test) tat RNA, with mean ratios of ~5:1 and 7:1 of unspliced to spliced RNA in PBL and M{phi}, respectively. In contrast, M{phi} from lymphopenic children contained much higher concentrations of unspliced tat RNA (P = 0.003, unpaired t-test), with a mean ratio of 27:1 of unspliced to spliced RNA. In these T cell depleted children, there was no evidence of tat fusion transcripts or cultivable virus in PBL (Table 2) . Only M{phi} harbored was infectious virus in this population.


View this table:
[in this window]
[in a new window]
 
Table 2. Quantification of HIV RNA in peripheral blood lymphocytes, pulmonary follicular dendritic cells, and pulmonary macrophages during late-stage pediatric AIDS

A detailed ultrastructural analysis of high-purity cell culture revealed HIV particles adherent to the cell body and dendritic processes of FDC (Fig. 2Di ). There was no evidence of intracytoplasmic particles or budding from the FDC plasma membrane. In contrast, pulmonary M{phi} demonstrated both intracytoplasmic and budding retroviral particles (Fig. 2Dii ), evidence of productive infection.

Latent reservoirs
HIV gag DNA localized to cells morphologically compatible with FDC, M{phi}, and lymphocytes in all tissues examined by PCR-ISH, including a few residual lymphocytes within the pulmonary interstitium (Fig. 3B ), lymph nodes (Fig. 3E ), and spleen from children with severe lymphoid atrophy. With the exception of lung, the numbers of cells harboring gag DNA were at least 20-fold greater than those expressing gag RNA, indicating that the majority of infections were nonproductive. Conversely, lung tissue contained a high proportion of cells transcriptionally active for HIV, with a ratio of 2:1 DNA- to RNA-positive cells, respectively. In children with late-stage disease, these transcriptionally active cells were exclusively alveolar and interstitial M{phi}.

Opportunistic lymphoproliferation
Because gamma herpesviruses have been linked to opportunistic lymphoproliferations in children [10 , 57 , 58 ] and animals [59 , 60 ] with chronic retroviral infections, we examined mucosal lymphoid tissues for viral transcripts indicative of EBV and HHV-8 infections. All children with lymphoid hyperplasia expressed EBV RNA, with as many as 20% of germinal center B cells in BALT harboring EBV EBER-1 RNA (Fig. 2E ). Interestingly, EBV was not detected in GALT, although these tissues showed similar levels of lymphoid expansion as lung. Lung tissues from children with widely disseminated EBV showed high numbers of HIV-infected cells with abundant virus. The HIV-positive M{phi} in these samples far exceeded the number of productively infected lymphocytes, a finding characteristic of hyperplastic lymph nodes without opportunistic infection. Surprisingly, children with lymphoid atrophy had similar numbers of HIV-infected M{phi}. EBV was not detected in tissues from children with lymphoid atrophy and HHV-8 was not present in any tissues examined. A retrospective analysis of serum showed that none of the subjects possessed measurable antibodies to HHV-8.

Collectively, these data suggest that the lung and gut, and to a much lesser extent the CNS, are primary sites of HIV replication in children with late-stage disease, with and without opportunistic infections.


arrow
DISCUSSION
 
Autopsy tissues from 2 cohorts of children were examined for anatomical and cellular reservoirs of persistent HIV replication. One group demonstrated multicentric opportunistic lymphoproliferations and the other showed severe lymphoid atrophy, two very contrasting pediatric AIDS-associated disease manifestations [10 , 44 , 57 ]. It was hypothesized that virus replication that occurs during late-stage disease, when CD4+ T cells are severely depleted, occurs predominantly within nonlymphoid cells. The basis for this hypothesis was the observation that during later stages of HIV infection, when lymphoid tissues characteristically display progressive loss of germinal centers leaving little if any remaining FDC-associated virus and only scattered productively infected CD4+ T lymphocytes, some children maintain high plasma viral load, often at set-points established during early infection (S. J. Brodie, unpublished results). As such, we applied a variety of techniques to measure productive infection and to identify cells harboring viral nucleic acid in situ.

The role of long-lived mononuclear phagocytes and dendritic cells as a source of HIV replication has been considered minimal, as few if any of these cells show productive infection in circulation or in lymphoid tissue. This is especially true during asymptomatic infection and during effective antiretroviral treatment [18 , 23 , 37 , 39 , 61 ]. Here, we show high numbers of HIV-infected M{phi} in the lung and colon from children during late-stage AIDS and a high proportion of these RNA-positive cells contained tat fusion transcripts, indicating there was post-transcriptional splicing and ligation, processes which have been associated with productive infection [15 , 41 56 ]. Others have shown CD4+ M{phi}, in addition to expressing a wide variety of HIV co-receptors essential for virus entry [8 , 62 63 64 ], are the principle HIV-infected cells in the CNS of patients with AIDS dementia [1 , 2 , 18 ], and adults and children with opportunistic pneumonia [7 , 8 , 10 ], and possibly some gastrointestinal disorders [9 , 13 ]. Moreover, their numbers are maintained or increased with disease progression and, unlike lymphocytes, are capable of producing large amounts of both intracellular and extracellular virus without succumbing to the lethal effects of productive viral infection [7 ].

FDC are capable of trapping large amounts of HIV on their cell surfaces in the form of antigen-antibody complexes and holding these complexes for long periods [22 23 24 25 26 ]. As such, FDC-bound virus is likely to serve as a source of new infection for activated CD4+ T cells trafficking through germinal centers congested with FDC-bound HIV [27 28 29 30 31 61 ]. Still, it is yet unclear if FDC are capable of supporting HIV replication in vivo, because there are many conflicting reports that support and refute their role as a source of HIV replication [32 33 34 35 36 , 65 ]. These discrepancies may be explained, in part, by differences in the ontogeny of dendritic cells; many FDC are morphologically similar but can be derived from several unrelated pathways of differentiation [25 , 32 , 66 ]. Moreover, because dendritic cells can be derived from a wide variety of different progenitor cells, it is likely that if productive infection occurs in this cell type it is restricted to specific lineages of FDC and/or perhaps occurs only within certain differentiation/maturation states [53 , 54 , 67 ].

Because FDC can proliferate and form extensive networks within secondary lymphoid tissues of individuals with AIDS and concurrent EBV infection [10 , 37 , 68 ], we took advantage of this as a means to examine FDC in situ, as well as harvest these cells from tissues and examine them at high-purity in vitro. Few studies have examined HIV replication in mature explant-derived FDC or in the context of dual in situ labeling. In vitro infection of monocyte-derived dendritic cells with lymphocytotropic and monocytotropic HIV showed that viral RNA was reverse transcribed to complete DNA provirus [53 ]. However, the infection was nonproductive, as judged from measuring the activity encoded by reverse transcriptase in culture supernatant. Thus, HIV infection of dendritic cells was restricted at a step post-entry. We show that HIV could enter mucosal FDC, reverse transcribe, and initiate transcription of at least the tat gene, but failed to process transcripts into translatable mRNA. Furthermore, we could not detect intracytoplasmic or budding viral particles after an exhaustive search using transmission electron microscopy, again suggesting that these cells did not support HIV replication.

A variety of herpesviruses have been implicated in pediatric lymphoproliferations [10 , 57 , 58 ]. We show that EBV localized to germinal center B lymphoblasts in tissues with hyperplastic BALT. This high incidence of EBV infection and virus replication may result from defective regulation of EBV in patients with AIDS or AIDS-related disorders [69 ]. Patients with opportunistic lymphoproliferations typically show high numbers of EBV-infected B cells in circulation as a consequence of profound defects in T-cell immunity [69 , 70 ]. Co-infection of B cells with HIV and EBV has also been described as a possible co-factor in the progression from polyclonal B cell proliferation to lymphoma, because both the upregulation of c-myc and activation of EBV can occur as a result of HIV infection [71 ]. We have shown previously that FDC in secondary lymphoid tissues are major sites for EBV replication and that proliferation of germinal center B cells in children with opportunistic lymphoproliferations results from EBV infection of B cells and/or their association with viral antigens bound to and/or expressed by FDC [10 ]. Others have shown that EBV can infect and transform FDC, although infection in vivo was rare as were FDC tumors [72 73 74 75 ]. Collectively, these data show that EBV is an important opportunist in germinal center hyperplasia, although the mechanisms of these events are not clear. Moreover, because M{phi} from children without opportunistic lymphoproliferations produced similar amounts of HIV, it is unlikely that co-viral interactions, such as EBV-mediated transactivation of the HIV LTR was responsible for the increases in HIV replication that occur during late-stage AIDS.

This study focuses attention on the persistence of HIV replication in children with chronic infection. We demonstrate that germinal center FDC in secondary lymphoid tissues are key reservoirs of immune-complexed HIV RNA and are likely to contribute to AIDS-associated lymphoproliferations; however, these cells do not support HIV replication, and failure to do so results from a post-transcriptional block in the virus life cycle. Moreover, gut and pulmonary M{phi} represent a lineage of cells that are permissive to HIV replication and contribute significantly to the high viral load seen in some children with severe CD4+ T cell depletion. It will be important to identify the molecular mechanisms that allow for these highly productive infections of M{phi}.


arrow
ACKNOWLEDGEMENTS
 
This study was supported by funds from the National Institutes of Health (AI36613, AI41535, AI30731, AI18029).

My thanks to Kurt Diem, Larry Stensland, and Lisa Glazatcheff for technical assistance, and to my colleagues Dr. Lawrence Corey, Dr. Andrew Johnson, and Dr. Bruce Patterson for helpful discussions and critical review of this article.


arrow
REFERENCES
 
    1
  1. Kerza-Kwiatecki, A. P., Amini, S. (1999) CNS as an HIV-1 reservoir: BBB and drug delivery J. Neurovirol. 5,113-114[Medline]
  2. 2
  3. An, S. F., Groves, M., Gray, F., Scaravilli, F. (1999) Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals J. Neuropathol. Exp. Neurol. 58,1156-1162[Medline]
  4. 3
  5. Coombs, R. W., Speck, C. E., Hughes, J. P., Lee, W., Sampoleo, R., Ross, S. O., Dragavon, J., Peterson, G., Hooton, T. M., Collier, A. C., Corey, L. (1998) Association between culturable human immunodeficiency virus type-1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood J. Infect. Dis. 177,320-330[Medline]
  6. 4
  7. Zhang, H., Dornadula, G., Beumont, M., Livornese, L., Jr, Van Uitert, B., Henning, K., Pomerantz, R. J. (1998) Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy N. Engl. J. Med. 339,1803-1809[Abstract/Free Full Text]
  8. 5
  9. Tscherning-Casper, C., Papadogiannakis, N., Anvret, M., Stolpe, L., Lindgren, S., Bohlin, A. B., Albert, J., Fenyo, E. M. (1999) The trophoblast epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy J. Virol. 73,9673-9678[Abstract/Free Full Text]
  10. 6
  11. Patterson, B. K., Behbahani, H., Muthui, D., Brodie, S. J., Andersson, J., Landay, A., Burki, Z., Garcia, P., Popek, E. (2000) Inhibition of and selection against vertical HIV transmission by the placentay 7th Conference on Retroviruses and Opportunistic Infections ,183 San Francisco, CA.
  12. 7
  13. Orenstein, J. M., Fox, C., Wahl, S. M. (1997) Macrophages as a source of HIV during opportunistic infections Science 276,1857-1861[Abstract/Free Full Text]
  14. 8
  15. Worgall, S., Connor, R., Kaner, R. J., Fenamore, E., Sheridan, K., Singh, R., Crystal, R. G. (1999) Expression and use of human immunofediciency virus type 1 coreceptors by human alveolar macrophages J. Virol. 73,5865-5874[Abstract/Free Full Text]
  16. 9
  17. Lewin-Smith, M., Wahl, S. M., Orenstein, J. M. (1999) Human immunodeficiency virus-rich multinucleated giant cells in the colon: a case report with transmission electron microscopy, immunohistochemistry, and in situ hybridization Mod. Pathol. 12,75-81[Medline]
  18. 10
  19. Brodie, S. J., de la Rosa, C., Howe, G., Travis, W. D., Diem, K. (1999) Pediatric AIDS-associated lymphocytic interstitial pneumonia and pulmonary arterio-occlusive disease: role of VCAM-1/VLA-4 adhesion pathway and human herpes viruses Am. J. Pathol. 154,1453-1464[Abstract/Free Full Text]
  20. 11
  21. Veazey, R. S., DeMaria, M., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H. L., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., Lackner, A. A. (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection Science 280,427-431[Abstract/Free Full Text]
  22. 12
  23. Kraehenbuhl, J. P. (1998) The gut-associated lymphoid tissue: a major site of HIV replication and CD4 cell loss Trends Microbiol 6,419-420[Medline]
  24. 13
  25. Kotler, D. P. (1999) Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy J. Infect. Dis. 179(3),S454-S456
  26. 14
  27. Zhang, Z. Q., Schuler, T., Zupancic, M., Wietgrefe, S., Staskus, K. A., Reimann, K. A., Reinhart, T. A., Rogan, M., Cavert, W., Miller, C. J., Veazey, R. S., Notermans, D., Little, S., Danner, S. A., Richman, D. D., Havlir, D., Wong, J., Jordan, H. L., Schacker, T. W., Racz, P., Tenner-Racz, K., Letvin, N. L., Wolinsky, S., Haase, A. T. (1999) Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells Science 286,1353-1357[Abstract/Free Full Text]
  28. 15
  29. Brodie, S. J., Berrey, M. M., Patterson, B. K., Zhu, T., Diem, K., Wood, B. L., Krieger, J. N., Corey, L. (2000) Comparison of cell-associated HIV DNA and RNA in triple drug treated versus untreated persons with primary HIV: evidence for persistent viral reservoirs 7th Conference on Retroviruses and Opportunistic Infections ,561 San Francisco, CA.
  30. 16
  31. Patterson, B. K., Mosiman, V. L., Cantarero, L., Bhattacharya, M., Goolsby, C. (1998) Detection of HIV-RNA-positive monocytes in peripheral blood of HIV-positive patients by simultaneous flow cytometric analysis of intracellular HIV RNA and cellular immunophenotype Cytometry 31,265-274[Medline]
  32. 17
  33. Zhu, T., Muthui, D., Holte, S., Chang, Y., Nickle, D., Feng, F., Shea, T., Berrey, M., Brodie, S. J., Self, S., Mullins, J., Corey, L. (2000) HIV latent reservoirs renewed by viral replication in activated CD4+ T lymphocytes, monocytes, and resting CD4+ T lymphocytes in patients receiving potent therapy 7th Conference on Retroviruses and Opportunistic Infections ,136 San Francisco, CA.
  34. 18
  35. Wahl, S. M., Greenwell-Wild, T., Peng, G., Hale-Donze, H., Orenstein, J. M. (1999) Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages J. Infect. Dis. 179(3),S457-S460
  36. 19
  37. Anderson, J. M. (2000) Multinucleated giant cells Curr. Opin. Hematol. 7,40-47[Medline]
  38. 20
  39. Van Furth, R. (1989) Origin and turnover of monocytes and macrophages Curr. Top. Pathol. 79,125-150[Medline]
  40. 21
  41. Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Salsela, K., Markowitz, M., Ho, D. D. (1997) Decay characteristics of HIV-1-infected compartments during combination therapy Nature 387,188-191[Medline]
  42. 22
  43. Fox, C. H., Tenner-Racz, K., Racz, P., Firpo, A., Pizzo, P. A., Fauci, A. S. (1991) Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA J. Infect. Dis. 164,1051-1057[Medline]
  44. 23
  45. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., Fauci, A. S. (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease Nature 362,355-358[Medline]
  46. 24
  47. Heath, S. L., Tew, J. G., Szakal, A. K., Burton, G. F. (1995) Follicular dendritic cells and human immunodeficiency virus infectivity Nature 377,740-744[Medline]
  48. 25
  49. Tenner-Racz, K., Racz, P. (1995) Follicular dendritic cells initiate and maintain infection of the germinal centers by human immunodeficieny virus Curr. Top. Microbiol. Immunol. 201,141-159[Medline]
  50. 26
  51. Schrager, L. K., Fauci, A. S. (1995) Human immunodeficiency virus: trapped but still dangerous Nature 377,680-681[Medline]
  52. 27
  53. Spiegel, H., Herbst, H., Niedobitek, G., Foss, H-D., Stein, H. (1992) Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 lymphoid tissues facilitating infection of CD4+ T-helper cells Am. J. Pathol. 140,15-22[Abstract]
  54. 28
  55. Fox, C. H., Cottler-Fox, M. (1992) The pathobiology of HIV infection Immunol. Today 13,353-365[Medline]
  56. 29
  57. Fox, C. H., Hoover, S., Currall, V. R., Bahre, H. J., Cottler-Fox, M. (1994) HIV in infected lymph nodes Nature 370,256[Medline]
  58. 30
  59. Cameron, P. U., Freudenthal, P. S., Barker, J. M., Gezelter, S., Inaba, K., Steinman, R. M. (1992) Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells Science 257,383-387
  60. 31
  61. Cameron, P., Pope, M., Granelli-Piperno, A., Steinman, R. M. (1996) Dendritic cells and the replication of HIV J. Leukoc. Biol. 59,158-171[Abstract]
  62. 32
  63. Weissman, D., Fauci, A. S. (1997) Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection Clin. Microbiol. Rev. 10,358-367[Abstract/Free Full Text]
  64. 33
  65. Schmitz, J., van Lunzen, J., Tenner-Racz, K., Grossschupff, G., Racz, P., Schmitz, H., Dietrich, M., Hufert, F. T. (1994) Follicular dendritic cells retain HIV particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia J. Immunol. 153,1352-1359[Abstract]
  66. 34
  67. Schmitz, J., van Lunzen, J., Tenner-Racz, K., Grossschupff, G., Racz, P., Schmitz, H., Dietrich, M., Hufert, F. (1994) Follicular dendritic cells are not productively infected with HIV in vivo Adv. Exp. Med. Biol. 355,165-168[Medline]
  68. 35
  69. Sprenger, R., Toellner, K. M., Schmetz, C., Luke, W., Stahl-Hennig, C., Ernst, M., Hunsmann, G., Schmitz, H., Flad, H. D., Gerdes, J., et al (1995) Follicular dendritic cells productively infected with immunodeficiency viruses transmit infection to T cells Med. Microbiol. Immunol. 184,129-134[Medline]
  70. 36
  71. Tacchetti, C., Favre, A., Moresco, L., Truni, M., Rizzo, F., Grossi, C. E., Ciccone, E. (1997) HIV is trapped and masked in the cytoplasm of lymph node follicular dendritic cells Am. J. Pathol. 150,533-542[Abstract]
  72. 37
  73. Cavert, W., Notermans, D. W., Staskus, K., Wietgrefe, S. W., Zupancic, M., Gebhard, K., Henry, K., Zhang, Z. Q., Mills, R., McDade, H., Schuwirth, C. M., Goudsmit, J., Danner, S. A., Haase, A. T. (1997) Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV infection Science 276,960-964[Abstract/Free Full Text]
  74. 38
  75. Tenner-Racz, K., von Stemm, A. M., Guhlk, B., Schmitz, J., Racz, P. (1994) Are follicular dendritic cells, macrophages and interdigitating cells of the lymphoid tissue productively infected by HIV? Res. Virol. 145,177-182[Medline]
  76. 39
  77. Zhang, Z. Q., Notermans, D. W., Sedgewick, G., Cavert, W., Wietgrefe, S., Zupancic, M., Gebhard, K., Henry, K., Boies, L., Chen, Z., Jenkins, M., Mills, R., McDade, H., Goodin, C., Schuwirth, C. M., Danner, S. A., Haase, A. T. (1998) Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection Proc. Natl. Acad. Sci. USA 95,1154-1159[Abstract/Free Full Text]
  78. 40
  79. Wong, J. K., Hezareh, M., Gunthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., Richman, D. D. (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia Science 278,1291-1300[Abstract/Free Full Text]
  80. 41
  81. Furtado, M. R., Callaway, D. S., Phair, J. P., Kunstman, K. J., Stantan, J. L., Macken, C. A., Perelson, A. S., Wolinsky, S. M. (1999) Persistence of HIV transcription in peripheral blood mononuclear cells in patients receiving potent antiretroviral therapy N. Engl. J. Med. 340,1614-1622[Abstract/Free Full Text]
  82. 42
  83. Zhang, L., Ramratnam, B., Tenner-Racz, K., He, Y., Vesanen, M., Lewin, S., Talal, A., Racz, P., Perelson, A., Kober, B. T., Markowitz, M., Ho, D. D. (1999) Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy N. Engl. J. Med. 340,1605-1613[Abstract/Free Full Text]
  84. 43
  85. Hockett, R. D., Kilby, J. M., Derdeyn, C. A., Saag, M. S., Sillerts, M., Squires, K., Chiz, S., Nowak, M. A., Shaw, G. M., Bucy, R. P. (1999) Constant mean viral copy number per infected cell in tissue regardless of high, low, or undetectable plasma HIV-1 RNA J. Exp. Med. 189,1545-1554[Abstract/Free Full Text]
  86. 44
  87. Pitt, J. (1991) Perinatal human immunodeficiency virus infection Clin. Perinatol. 18,227-239[Medline]
  88. 45
  89. Brodie, S. J., Sasseville, V. G., Reimann, K., Simon, M. A., Sehgal, P. K., Ringler, D. J. (1994) Macrophage function in simian AIDS: killing defects in vivo are independent of macrophage infection, associated with alterations in Th phenotype, and are reversible with IFN-g J. Immunol. 153,5790-5801[Abstract]
  90. 46
  91. Brodie, S. J., Pearson, L. D., Zink, M. C., Bickle, H. M., Anderson, B. C., Marcom, K. A., DeMartini, J. C. (1995) Ovine lentivirus expression and disease: virus replication, but not entry, is restricted to macrophages of specific tissues Am. J. Pathol. 146,1-13[Medline]
  92. 47
  93. Brodie, S. J., Wilson, W. C., O’Hearn, P. M., Muthui, D., Diem, K., Pearson, L. D. (1998) The effects of pharmocological and lentivirus-induced immunosuppression on orbivirus pathogenesis: assessment of blood monocytes and tissues by in situ hybridization and reverse transcription in situ PCR J. Virol. 72,5599-5609[Abstract/Free Full Text]
  94. 48
  95. Brodie, S. J., Patterson, B. K., Lewinsohn, D. A., Diem, K., Spach, D., Greenberg, P. D., Riddell, S. R., Corey, L. (2000) Adoptively transferred HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize in sites of HIV replication, granzyme-B expression, and cell death. J. Clin. Invest., in press.
  96. 49
  97. Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Bassett, R. L., Timpone, J., Baruch, A., Jones, M., Facey, K., Whitacre, C., McAuliffe, V. J., Friedman, H. M., Merigan, T. C., Reichman, R. C., Hooper, C., Corey, L. (1996) Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine: AIDS Clinical Trials Group N. Engl. J. Med. 334,1011-1017[Abstract/Free Full Text]
  98. 50
  99. Schacker, T., Collier, A. C., Hughes, J., Shea, T., Corey, L. (1996) Clinical and epidemiologic features of primary HIV infection Ann. Intern. Med. 125,257-264[Abstract/Free Full Text]
  100. 51
  101. Diamond, C., Brodie, S. J., Koelle, D. M., Huang, M-L., Diem, K., Muthui, D., Krieger, J. N., Corey, L. (1998) Human herpes virus eight in prostate tissue on men with Kaposi’s sarcoma J. Virol. 72,6223-6227[Abstract/Free Full Text]
  102. 52
  103. Brodie, S. J., Krieger, J. N., Diamond, C., Diem, K., Corey, L. (2000) Kaposi’s sarcoma-associated human herpes virus eight: localization of viral gene expression and viral latency Patterson, B. K. eds. Techniques in Localization of Gene Expression ,97-106. Birkhauser Boston.
  104. 53
  105. Hausser, G. A., Hultgren, C., Akagawa, K., Tsunetsugu-Yokota, Y., Meyerhans, A. (1995) Infection of cultured immature dendritic cells with human immunodeficiency virus type I Adv. Exp. Med. Biol. 378,477-479[Medline]
  106. 54
  107. Triozzi, P. L., Aldrich, W. (1997) Phenotypic and functional differences between human dendritic cells derived in vitro from hematopoietic progenitors and from monocytes/macrophage J. Leukoc. Biol. 61,600-608[Abstract]
  108. 55
  109. Brodie, S. J., Lewinsohn, D. A., Patterson, B. K., Jiyamapa, D., Krieger, J., Corey, L., Greenberg, P. D., Riddell, S. R. (1999) In vivo migration and function of transferred HIV-specific cytotoxic T cells Nat. Med. 5,34-41[Medline]
  110. 56
  111. Furtado, M. R., Balachandran, R., Gupta, P., Wolinsky, S. M. (1991) Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel TAT-ENV fusion protein Virology 185,258-270[Medline]
  112. 57
  113. Andiman, W. A., Eastman, R., Martin, K., Katz, B. Z., Rubinstein, A., Pitt, J., Pahwa, S., Miller, G. (1985) Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS Lancet 2,1390-1393[Medline]
  114. 58
  115. Barbera, J. A., Hayashi, S., Hegele, R. G., Hogg, J. C. (1992) Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization Am. Rev. Respir. Dis. 145,940-946[Medline]
  116. 59
  117. Weck, K. E., Dal-Canto, A. J., Gould, J. D., O’Guin, A. K., Roth, K. A., Saffitz, J. E., Speck, S. H., Virgin, H. W. (1997) Murine gamma-herpesvirus 68 causes severe large-vessel ateritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease Nat. Med. 3,1346-1353[Medline]
  118. 60
  119. Desrosiers, R. C., Sasseville, V. G., Czajak, S. C., Zhang, X., Mansfield, K. G., Kaur, A., Johnson, R. P., Lackner, A. A., Jung, J. U. (1997) A herpesvirus of rhesus monkeys related to human Kaposi’s sarcoma-associated herpesvirus J. Virol. 71,9764-9769[Abstract/Free Full Text]
  120. 61
  121. Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., Hasse, A. T. (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS Nature 362,359-362[Medline]
  122. 62
  123. Ayehunie, S., Garcia-Zepeda, E. A., Hoxie, J. A., Horuk, R., Kupper, T. S., Luster, A. D., Ruprect, R. M. (1997) Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors Blood 90,1379-1386[Abstract/Free Full Text]
  124. 63
  125. Rubbert, A., Combadiere, C., Ostrowski, M., Arthos, J., Dybul, M., Machado, E., Cohn, M. A., Hoxie, J. A., Murphy, P. M., Fauci, A. S., Weissman, D. (1998) Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry J. Immunol. 160,3933-3941[Abstract/Free Full Text]
  126. 64
  127. Weissman, D., Rubbert, A., Combadiere, C., Murphy, P. M., Fauci, A. S. (1997) Dendritic cells express and use multiple HIV coreceptors Adv. Exp. Med. Biol. 417,401-406[Medline]
  128. 65
  129. Orenstein, J. M., Fox, C., Tenner-Racz, K., Racz, P. (1997) Is HIV found in the cytoplasm of dendritic cells? Am. J. Pathol. 151,1173-1176[Medline]
  130. 66
  131. Gluckman, J. C., Canque, B., Chapuis, F., Rosenzwajg, M. (1997) In vitro generation of human dendritic cells and cell therapy Cytokines Cell. Mol. Ther. 3,187-196[Medline]
  132. 67
  133. Paluka, K. A., Taguet, N., Sanchez-Chapuis, F., Gluckman, J. C. (1998) Dendritic cells as the terminal stage of monocyte differentiation J. Immunol. 160,4587-4595[Abstract/Free Full Text]
  134. 68
  135. Nagira, M., Sato, A., Miki, S., Imai, T., Yoshie, O. (1999) Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissues Virology 264,422-426[Medline]
  136. 69
  137. Birx, D. L., Redfield, R. R., Tosato, G. (1986) Defective regulation of Epstein-Barr virus infection in patients with AIDS or AIDS-related disorders N. Engl. J. Med. 314,874-879[Abstract]
  138. 70
  139. Carbone, A., Gloghini, A., Volpe, R., Boiocchi, M., Tirelli, U. (1994) High frequency of Epstein-Barr virus latent membrane protein-1 expression in acquired immunodeficiency syndrome-related Ki-1 (CD30)-positive anaplastic large-cell lymphomas Am. J. Clin. Pathol. 101,768-772[Medline]
  140. 71
  141. Laurence, J., Astrin, S. M. (1991) Human immunodeficiency virus induction of malignant transformation in human B lymphocytes Proc. Natl. Acad. Sci. USA 88,7635-7639[Abstract/Free Full Text]
  142. 72
  143. Lindhout, E., Lakeman, A., Mevissen, M. L., de Groot, C. (1994) Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines J. Exp. Med. 179,1173-1184[Abstract/Free Full Text]
  144. 73
  145. Arber, D. A., Weiss, L. M. (1996) EBV in follicular dendritic cells Am. J. Surg. Pathol. 20,1426-1427[Medline]
  146. 74
  147. Arber, D. A., Kamel, O. W., van de Rijn, M., Davis, R. E., Medeiros, L. J., Jaffe, E. S., Weiss, L. M. (1995) Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor Hum. Pathol. 26,1093-1098[Medline]
  148. 75
  149. Shek, T. W., Luk, I. S. (1996) Inflammatory tumor Am. J. Surg. Pathol. 20,900-902[Medline]



This article has been cited by other articles:


Home page
ChestHome page
M. D. Wewers, S. Lemeshow, A. Lehman, T. L. Clanton, and P. T. Diaz
Lung CD4 Lymphocytes Predict Survival in Asymptomatic HIV Infection
Chest, October 1, 2005; 128(4): 2262 - 2267.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. R. Coberley, J. J. Kohler, J. N. Brown, J. T. Oshier, H. V. Baker, M. P. Popp, J. W. Sleasman, and M. M. Goodenow
Impact on Genetic Networks in Human Macrophages by a CCR5 Strain of Human Immunodeficiency Virus Type 1
J. Virol., November 1, 2004; 78(21): 11477 - 11486.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. M. Hanley, H. L. B. Kiefer, A. C. Schnitzler, J. E. Marcello, and G. A. Viglianti
Retinoid-Dependent Restriction of Human Immunodeficiency Virus Type 1 Replication in Monocytes/Macrophages
J. Virol., March 15, 2004; 78(6): 2819 - 2830.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
C. Habasque, F. Aubry, B. Jegou, and M. Samson
Study of the HIV-1 receptors CD4, CXCR4, CCR5 and CCR3 in the human and rat testis
Mol. Hum. Reprod., May 1, 2002; 8(5): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Chougnet, C. Freitag, M. Schito, E. K. Thomas, A. Sher, and G. M. Shearer
In Vivo CD40-CD154 (CD40 Ligand) Interaction Induces Integrated HIV Expression by APC in an HIV-1-Transgenic Mouse Model
J. Immunol., March 1, 2001; 166(5): 3210 - 3217.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. J. Montaner, C.-F. Perno, and S. Crowe
Macrophage infection by HIV-1: focus on viral reservoirs and pathogenesis
J. Leukoc. Biol., September 1, 2000; 68(3): 301 - 302.
[Full Text] [PDF]


This Article
Right arrow Correction (v83,p797)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodie, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodie, S. J.